2020-11-13 • Updated
This is what happened this week. Pfizer announced that basically its vaccine works well and is ready for distribution. The market immediately shot its stock from $36 to $42. Next, people started commenting that having the vaccine ready is not enough – there are quite a few problems around it, such as storage, delivery, pricing, etc. And the market went “ok then, I’m getting back down” – so the stock dropped to almost exactly where it was before the spike. Will it drop further? Possible, but the upside potential is still there – technically, and fundamentally. Very probably, in a week or so, the share price will penetrate $39, just on a milted upward curve. But that’s not the most interesting thing: Moderna has just announced that its vaccine is also waiting for the release of the trial results. Let’s look at the chart.
Moderna share price was below 75$ when the announcement was made. Momentarily, the stock went all the way to $88 – a more than 10% rise just in a couple of days. So far, it is staying in that range but will it continue to $95? That may depend on what the news are on the trial results. If they are as good – or, preferably, better than – those of Pfizer, very probably it will go up to $88 and beyond. Otherwise, it will drop the same as Pfizer did, to $75. Therefore, follow the news from Moderna and act quickly if you want to benefit from those movements.
Don't know how to trade stocks? Here are some simple steps.
Crude oil futures surged on Monday due to disruptions in Russian refining capacity caused by Ukrainian drone strikes and Moscow's decision to cut output to comply with OPEC+ targets. The West Texas Intermediate (WTI) contract for May settled at $81.95 a barrel, up $1.32, while the Brent contract for May settled at $86.57 a barrel, also up $1.32. Russia instructed...
Bearish scenario: Sales below 80.00 with TP1: 79.60... Anticipated bullish scenario: Intraday purchases above 80.70 with TP: 81.50...
Brent oil is currently on a bullish trend, facing resistance near $84 and supported by the 200-day EMA. Breaking above this level could lead to a climb towards $90. Short-term support is observed around $80, backed by the 50-day EMA. As summer approaches and travel increases, crude oil tends to benefit from seasonal patterns. Despite temporary setbacks, buying...
Jerome H. Powell, the Federal Reserve chair, stated that the central bank can afford to be patient in deciding when to cut interest rates, citing easing inflation and stable economic growth. Powell emphasized the Fed's independence from political influences, particularly relevant as the election season nears. The Fed had raised interest rates to 5.3 ...
Hello again my friends, it’s time for another episode of “What to Trade,” this time, for the month of April. As usual, I present to you some of my most anticipated trade ideas for the month of April, according to my technical analysis style. I therefore encourage you to do your due diligence, as always, and manage your risks appropriately.
Bearish scenario: Sell below 1.0820 / 1.0841... Bullish scenario: Buy above 1.0827...
FBS maintains a record of your data to run this website. By pressing the “Accept” button, you agree to our Privacy policy.
Your request is accepted.
A manager will call you shortly.
Next callback request for this phone number
will be available in
If you have an urgent issue please contact us via
Live chat
Internal error. Please try again later
Don’t waste your time – keep track of how NFP affects the US dollar and profit!
|
